Recompensation of Liver Cirrhosis by TIPS Reduces Epithelial Cell Death Markers, Translating Into Improved Clinical Outcome
Liver International · 2025
DOI: 10.1111/liv.16156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Felix Piecha und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Liver Cirrhosis, Hypertension, Portal, Portasystemic Shunt, Transjugular Intrahepatic, Keratin-18. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation Dr. Brauns, Universitätsklinikum Hamburg-Eppendorf, Deutsches Zentrum für Infektionsforschung.
Abstract (Originalsprache)
Background and Aims Portal hypertension is the main pathophysiological driver of decompensation in patients with liver cirrhosis. Epithelial cell death markers, m30 and m65, correlate with hepatic injury and predict outcomes across various stages of liver disease. We aim (i) to evaluate whether portal hypertension itself contributes to liver outcome‐relevant epithelial injury, and (ii) to analyse the capacity of m30/m65 to predict outcome in patients receiving a transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites.
Methods
Sixty‐six patients undergoing TIPS placement for refractory ascites and 20 patients with compensated cirrhosis as controls were prospectively enrolled in this monocentric cohort study. Epithelial cell death markers were analysed pre‐TIPS, as well as 1–3 and 6–9 months post‐TIPS. The capacity of baseline levels of m30/m65 in predicting six‐month transplant‐free survival rates was analysed by multivariable Cox proportional hazards regression.
Results
Levels of m30 and m65 were higher in patients with decompensated cirrhosis (pre‐TIPS) compared with compensated cirrhosis (controls). Following correction of portal hypertension by TIPS and recompensation, both markers decreased over time, reaching levels comparable to patients with compensated cirrhosis. On multivariable analysis, pre‐TIPS baseline levels of m30 and m65 were not predictive for six‐month survival.
Conclusion
Correction of portal hypertension via TIPS reduces levels of epithelial cell death markers, indicating that portal hypertension is a driver of outcome‐relevant, hepatic cell death in patients with decompensated cirrhosis. Baseline m30/m65 values do not affect six‐month survival rates, which suggests that TIPS placement overcomes the unfavourable spontaneous prognosis otherwise indicated by elevated baseline m30/65 levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
- Center for Experimental Medicine, Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Protozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
- Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Ifi-Institute for Interdisciplinary Medicine, Hamburg, Germany.
ORCID-Profile: Felix Piecha, Peter Hübener
Förderung
- Foundation Dr. Brauns
- Universitätsklinikum Hamburg-Eppendorf
- Deutsches Zentrum für Infektionsforschung
Zitieren
APA
Piecha, F., Jahn, B. V., Köntopf, J., Koop, A., Ozga, A. K., Al-Jawazneh, A., Harberts, A., Riedel, C., Buggisch, P., Benten, D., Hübener, P., Adam, G., Huber, S., Lohse, A. W., Bannas, P., & Kluwe, J. (2025). Recompensation of Liver Cirrhosis by TIPS Reduces Epithelial Cell Death Markers, Translating Into Improved Clinical Outcome. Liver International. https://doi.org/10.1111/liv.16156
Vancouver
Piecha F, Jahn BV, Köntopf J, Koop A, Ozga AK, Al-Jawazneh A, et al. Recompensation of Liver Cirrhosis by TIPS Reduces Epithelial Cell Death Markers, Translating Into Improved Clinical Outcome. Liver International. 2025. doi:10.1111/liv.16156
BibTeX
@article{Piecha2025,
author = {Piecha, Felix and Jahn, Beatrice-Victoria and Köntopf, Johannes and Koop, Anja and Ozga, Ann-Kathrin and Al-Jawazneh, Amirah and Harberts, Aenne and Riedel, Christoph and Buggisch, Peter and Benten, Daniel and Hübener, Peter and Adam, Gerhard and Huber, Samuel and Lohse, Ansgar W and Bannas, Peter and Kluwe, Johannes},
title = {Recompensation of Liver Cirrhosis by TIPS Reduces Epithelial Cell Death Markers, Translating Into Improved Clinical Outcome},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.16156}
}
EUVIMED